Novartis AG vs AstraZeneca PLC
Market cap comparison over time
Novartis AG
$255.0B
Rank #59
AstraZeneca PLC
$258.3B
Rank #56
Market Cap Over Time
Key Moments
- AstraZeneca PLC overtook Novartis AG by 2020
Year-by-Year Comparison
| Year | Novartis AG | AstraZeneca PLC | Leader |
|---|---|---|---|
| 2026 | $255.0B | $258.3B | AstraZeneca PLC |
| 2025 | $227.3B | $282.2B | AstraZeneca PLC |
| 2024 | $177.6B | $196.9B | AstraZeneca PLC |
| 2023 | $163.8B | $198.1B | AstraZeneca PLC |
| 2022 | $146.3B | $195.3B | AstraZeneca PLC |
| 2021 | $134.5B | $163.9B | AstraZeneca PLC |
| 2020 | $134.7B | $136.9B | AstraZeneca PLC |
| 2019 | $142.4B | $132.8B | Novartis AG |
| 2018 | $110.8B | $97.9B | Novartis AG |
| 2017 | $104.0B | $85.9B | Novartis AG |
| 2016 | $89.6B | $64.5B | Novartis AG |
| 2015 | $100.4B | $76.6B | Novartis AG |
| 2014 | $103.4B | $76.2B | Novartis AG |
| 2013 | $76.6B | $61.7B | Novartis AG |
| 2012 | $59.2B | $46.3B | Novartis AG |
| 2011 | $52.5B | $42.7B | Novartis AG |
| 2010 | $51.1B | $40.3B | Novartis AG |
| 2009 | $50.7B | $38.9B | Novartis AG |
| 2008 | $44.5B | $32.3B | Novartis AG |
| 2007 | $50.6B | $32.3B | Novartis AG |
| 2006 | $55.9B | $39.1B | Novartis AG |
| 2005 | $53.9B | $34.5B | Novartis AG |
| 2004 | $43.8B | $25.2B | Novartis AG |
| 2003 | $42.0B | $32.9B | Novartis AG |
| 2002 | $36.9B | $23.4B | Novartis AG |
| 2001 | $43.1B | $30.5B | Novartis AG |
| 2000 | $50.7B | $33.1B | Novartis AG |
| 1999 | $40.7B | $25.7B | Novartis AG |
| 1998 | $46.3B | $27.2B | Novartis AG |
| 1997 | $40.1B | $21.4B | Novartis AG |
| 1996 | $24.5B | $16.3B | Novartis AG |
| 1995 | $16.9B | $11.1B | Novartis AG |